A carregar...
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial
Dose-finding studies that aim to evaluate the safety of single agents are becoming less common, and advances in clinical research have complicated the paradigm of dose finding in oncology. A class of more complex problems, such as targeted agents, combination therapies and stratification of patients...
Na minha lista:
| Publicado no: | Pharm Stat |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608237/ https://ncbi.nlm.nih.gov/pubmed/25962576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1686 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|